Maghemite-containing PLGA-PEG-based polymeric nanoparticles for siRNA delivery: Toxicity and silencing evaluation

Emmanuel Lellouche, Erica Locatelli, Liron Limor Israel, Maria Naddaka, Ella Kurlander, Shulamit Michaeli, Jean Paul Lellouche, Mauro Comes Franchini

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Gene therapy based on small interfering RNA (siRNA) has emerged as an exciting new therapeutic approach. In this work, incorporation of PEI into poly(d,l-lactide-co-glycolide)-poly(ethylene glycol) (PLGA-b-PEG) particles has been shown to be quite effective in the development of corresponding gene delivery systems, and encapsulation of magnetic nanoparticles as an MRI contrast agent, resulted in unique theranostic nanoparticles.

Original languageEnglish
Pages (from-to)26912-26920
Number of pages9
JournalRSC Advances
Volume7
Issue number43
DOIs
StatePublished - 2017

Bibliographical note

Publisher Copyright:
© 2017 The Royal Society of Chemistry.

Fingerprint

Dive into the research topics of 'Maghemite-containing PLGA-PEG-based polymeric nanoparticles for siRNA delivery: Toxicity and silencing evaluation'. Together they form a unique fingerprint.

Cite this